The Galactosemia Podcast podcast

Why BridgeBio Stopped Galactosemia Gene Therapy

0:00
18:34
Spol 15 sekunder tilbage
Spol 15 sekunder frem

BridgeBio recently stopped their research and development of gene therapy for Galactosemia. This came as a shock to many of us. I talked to the CEO of BridgeBio on the phone, and in this episode I report back what he told me. 

Flere episoder fra "The Galactosemia Podcast"